Bradley Foster & Sargent Inc. CT Decreases Stock Position in The Procter & Gamble Company (NYSE:PG)

Bradley Foster & Sargent Inc. CT lessened its stake in The Procter & Gamble Company (NYSE:PG) by 1.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 231,451 shares of the company’s stock after selling 3,987 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Procter & Gamble were worth $38,171,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in PG. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $29,000. Transcendent Capital Group LLC bought a new position in Procter & Gamble during the fourth quarter worth $31,000. Ruedi Wealth Management Inc. lifted its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares during the last quarter. POM Investment Strategies LLC bought a new position in Procter & Gamble during the second quarter worth $34,000. Finally, Vima LLC bought a new position in Procter & Gamble during the fourth quarter worth $35,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Procter & Gamble

In related news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the transaction, the chief executive officer now owns 263,537 shares in the company, valued at approximately $44,508,763.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the transaction, the chief executive officer now owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. The disclosure for this sale can be found here. Insiders sold 375,553 shares of company stock worth $63,829,141 in the last quarter. 0.17% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. BNP Paribas assumed coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. Barclays reduced their price objective on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating on the stock in a research note on Thursday, August 1st. Royal Bank of Canada increased their target price on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Evercore ISI increased their target price on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Finally, Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Seven investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $175.79.

Procter & Gamble Price Performance

NYSE:PG opened at $175.93 on Wednesday. The business’s 50-day moving average price is $169.80 and its 200 day moving average price is $165.49. The firm has a market cap of $415.22 billion, a P/E ratio of 28.75, a PEG ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $177.94. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The firm had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.37 earnings per share. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s payout ratio is currently 65.85%.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.